Cell Therapy Solutions | Cell and Gene Therapy Equipment | Corning

Scaling MSC therapies is simpler and less risky with the right tools, such as stacked modular cell culture systems and closed-system solutions.

Learn about cutting-edge advancements in mesenchymal stromal cell (MSC) therapies for graft-versus-host disease (GvHD) and streamlined strategies for scaling up production.

This whitepaper focuses on four promising approaches: stimulating stem cell homing for in situ repair, transplanting organoids to repair minor tissue injury, tissue engineering, and using interspecies chimerism to produce functional organs for transplantation.

This whitepaper leverages Corning’s extensive expertise in seeding, expanding, and harvesting stem cells.

In this playbook, we’ve asked Corning Life Sciences experts to explore the changing landscape of stem cell research and cell therapy production and how emerging solutions have facilitated a new era of more effective and efficient workflows.

This guide explores what researchers should consider when creating a risk-mitigating adherent culture process for cell and gene therapy scale-up.

Cell and gene therapies offer tremendous promise, but scaling up cell production can be a challenge. This animation introduces the Corning Ascent Fixed Bed Reactor system, which combines the best of both worlds…an adherent-friendly environment with the automation and control of a suspension system.

Discover which Corning products help Dr. Guillaume Churlaud and his team produce cell & gene therapy drugs to treat patients suffering from autoimmune, hematological, and cardiac diseases, and so much more.

Watch the video or read the poster to learn how the Ascent fixed bed bioreactor system enabled the Gittes lab to continuously monitor and control the temperature, pH, and DO of their HEK293 cells, resulting in higher viral productivity.

Which cell culture method is right for your lab? Use this infographic to help you achieve your goals!

Learn about the latest trends in viral vector production to help enhance vaccine research development.

The trajectory of personalized medicine is at a pivotal moment, owing to our expanding understanding of human biology and disease behavior and access to dynamic tools that continually increase our knowledge

Discover four best practices for scaling up vaccine production process development from an expert in the field.

Making the right choice requires scientists to consider a range of factors, from surface area to scale.

See how researchers were able to successfully yield over 870 million human bone marrow-derived MSCs can be obtained from a single HYPERStack 36-layer cell culture vessel.

AAV and LV vectors can be appealing alternatives to adenoviruses for researchers engaged in viral vector work. Let’s compare the two.

Vessel choice is influenced by a myriad of operational and biological factors, such as scale, resources, timing, cell type, and how much — or how little — culture inspection and parameter control is required. 

There are five important things to consider when determining how to customize your cell culture media or reagent.

Download this guide to improving your scale-up efficiency with HYPER technology from Corning.